Revenue GrowthSustained double‑digit top‑line growth and 7% ARR expansion indicate improving product adoption and recurring revenue depth. Over the next 2–6 months this supports scaling unit economics, provides base demand for upsell, and reduces reliance on one‑off revenue as recurring streams expand.
Baxter/GPO Market AccessInclusion in a major GPO materially expands distribution and procurement reach into U.S. hospitals, creating a structural channel for enterprise deals. Over time this can shorten procurement friction, increase qualified opportunities, and amplify addressable market access versus strictly direct sales.
AI & SDLC ProductivityMeaningful engineering productivity gains from AI and SDLC redesign should accelerate feature delivery and reduce incremental development cost per deployment. This durable efficiency can improve margin prospects, speed time‑to‑market for pilots, and support faster, more predictable commercial rollouts.